Table 1.
Clinical and angiographic characteristics of the study group.
| Variable | Ectatic (n = 65) |
Obstructive (n = 62) |
Control (n = 44) | p-Value |
|---|---|---|---|---|
| Patient Characteristics | ||||
| Height, cm | 175.64 ± 6.62 | 170.32 ± 9.90 | 169.61 ± 10.34 | 0.04 |
| Weight, kg | 89.35 ± 12.97 | 86.14 ± 17.19 | 81.25 ± 19.24 | 0.17 |
| BMI | 28.96 ± 3.82 | 29.62 ± 4.92 | 28.22 ± 6.30 | 0.49 |
| Comorbidities | ||||
| Stable angina, n (%) | 5 (7.7) | 2 (3.2) | 10 (22.7) | 0.003 |
| Silent ischemia, n (%) | 3 (4.6) | 0 (0.0) | 2 (4.5) | 0.23 |
| Unstable angina, n (%) | 28 (43.1) | 18 (29.0) | 29 (65.9) | 0.001 |
| NSTEMI, n (%) | 13 (20.0) | 18 (29.0) | 4 (9.1) | 0.04 |
| STEMI, n (%) | 22 (33.8) | 29 (46.8) | 8 (18.2) | 0.001 |
| Hypertension, n (%) | 51 (78.5) | 48 (77.4) | 29 (69.0) | 0.50 |
| Diabetes, n (%) | 20 (30.8) | 18 (29.0) | 15 (35.7) | 0.76 |
| Dyslipidemia, n (%) | 54 (83.1) | 55 (88.7) | 34 (81.0) | 0.50 |
| Smoker, n (%) | 35 (53.8) | 37 (59.7) | 18 (42.9) | 0.23 |
| Prior of angina, n (%) | 2 (3.1) | 4 (6.5) | 1 (2.4) | 0.51 |
| Prior typical/atypical chest pain, n (%) | 1 (1.5) | 1 (1.6) | 2 (4.8) | 0.50 |
| Prior CAD, n (%) | 23 (35.4%) | 26 (41.9) | 7 (16.7) | 0.02 |
| Pharmacological Treatment | ||||
| Statins, n (%) | 51 (81.0) | 58 (96.7) | 27 (79.4) | 0.014 |
| Diuretics, n (%) | 15 (23.8) | 15 (25.0) | 9 (26.5) | 0.95 |
| Insulin, n (%) | 1 (1.6) | 1 (1.7) | 2 (5.9) | 0.37 |
| ACEi or ARB, n (%) | 39 (61.9) | 45 (75.0) | 20 (58.8) | 0.18 |
| Aspirin, n (%) | 55 (87.3) | 60 (100) | 23 (67.6) | 0.001 |
| CCB, n (%) | 6 (9.5) | 12 (20.0) | 8 (23.5) | 0.13 |
| Nitrates, n (%) | 7 (11.1) | 4 (6.7) | 2 (5.9) | 0.56 |
| Oral hypoglycaemic, n (%) | 9 (14.3) | 10 (16.7) | 9 (26.5) | 0.31 |
Continuous variables are shown as mean ± standard deviation (SD). Nominal variables are presented as a percentage in brackets. BMI, body mass index. NSTEMI, non-ST-elevation myocardial infarction. STEMI, ST-elevation myocardial infarction. CAD, history of coronary artery disease prior to myocardial infarction. ACEi, angiotensin-converting-enzyme inhibitor. ARB, angiotensin receptor blockers. CCB, Calcium channel blocker.